Literature DB >> 12099659

Surgical therapy for loco-regional recurrence and distant metastasis of gastric cancer.

T Lehnert1, B Rudek, K Buhl, M Golling.   

Abstract

The appearence of distant metastases or local recurrence is assumed to render gastric cancer incurable. However, experience with colorectal cancer has shown that patients with recurrent disease may have a chance for cure, if recurrent or metastatic disease can be completely resected. Since improved imaging allows detection of ever smaller tumour deposits, we have reviewed the pertinent literature to determine the current surgical options for recurrent or metastatic gastric cancer. Metastatic disease or local recurrence is rarely resectable. Tumour recurrence in the remnant stomach after partial gastrectomy can be treated by secondary total gastrectomy and may occasionally result in long-term survival. Other types of local recurrence are generally not amenable to complete resection. The same is true for distant metastases. If, however, distant metasases are technically resectable, 5 year survival of approximately 20% has been documented. Solitary and late appearing metachronous tumours are associated with an improved prognosis. As a consequence resection of distant metastases should be considered, because the risk of metastasectomy is generally low and there is no alternative treatment with a chance for cure. Copyright 2002 Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12099659     DOI: 10.1053/ejso.2002.1260

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  27 in total

1.  Treatment for isolated loco-regional recurrence of gastric adenocarcinoma: does surgery play a role?

Authors:  Fabio Carboni; Pasquale Lepiane; Roberto Santoro; Riccardo Lorusso; Pietro Mancini; Massimo Carlini; Eugenio Santoro
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

2.  Clinicopathologic features of remnant gastric cancer over time following distal gastrectomy.

Authors:  De-Wei Zhang; Biao Dong; Zhen Li; Dong-Qiu Dai
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

3.  Jejunal pouch recurrence after extended surgery for gastric cancer: report of a case.

Authors:  Konstantinos Blouhos; Konstantinos A Boulas; Konstantinos Tsalis; Anestis Hatzigeorgiadis
Journal:  J Gastrointest Cancer       Date:  2014-12

4.  miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer.

Authors:  Dacheng Wen; Songhe Li; Fujian Ji; Hong Cao; Weidong Jiang; Jiaming Zhu; Xuedong Fang
Journal:  Tumour Biol       Date:  2013-01-09

5.  Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancer.

Authors:  J Lee; H I Yoon; S Y Rha; W J Hyung; Y C Lee; J S Lim; H S Kim; W S Koom
Journal:  Clin Transl Oncol       Date:  2017-05-05       Impact factor: 3.405

6.  Adrenal metastases from adenocarcinoma of the esophagogastric junction: adrenalectomy and long-term survival.

Authors:  Uberto Fumagalli; Stefano de Carli; Stefano de Pascale; Lorenza Rimassa; Mario Bignardi; Riccardo Rosati
Journal:  Updates Surg       Date:  2010-08

7.  Long-term survival after resection of metachronous bilateral adrenal metastases of mucinous gastric carcinoma: report of a case.

Authors:  Yasuji Mokuno; Makoto Katayama; Yutaka Ogura; Keiko Kimura; Katsuyoshi Koh
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

8.  Bone recurrence after curative resection of gastric cancer.

Authors:  Jae Myung Park; Kyo Young Song; Joo Hyun O; Won Chul Kim; Myung-Gyu Choi; Cho Hyun Park
Journal:  Gastric Cancer       Date:  2012-09-08       Impact factor: 7.370

9.  Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer.

Authors:  Chang-Ming Huang; Jian-Xian Lin; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Bi-Juan Lin; Hui-Shan Lu
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

10.  Surgical treatment of recurrent gastric cancer.

Authors:  Alvaro Díaz de Liaño; Concepción Yarnoz; Rubén Aguilar; Cristina Artieda; Héctor Ortiz
Journal:  Gastric Cancer       Date:  2008-03-29       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.